Balance sheet of Speciality Medicines is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Speciality Medicines is increasing.
Latest net debt of Speciality Medicines is ₹3.76 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹2.58 Crs.

Yes, profit is increasing.
The profit of Speciality Medicines is ₹8.61 Crs for Mar 2025, ₹2.93 Crs for Mar 2024 and ₹1.69 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Speciality Medicines latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances